The risk of cardiovascular comorbidity in children with Behçet's disease

Selcan Demir1, Ali Duzova2, Tevfik Karagoz3

  • 1Department of Pediatric Rheumatology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey.

PubMed

Insights

Cardiovascular risks in pediatric Behçet's disease (BD) patients were assessed. While some indicators were similar, vascular involvement showed potential aortic stiffness, suggesting comprehensive cardiovascular evaluation for all pediatric BD patients is crucial.

Area of Science:

  • Pediatric Rheumatology
  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • Behçet's disease (BD) can lead to significant long-term cardiovascular morbidity in pediatric patients.
  • Assessing cardiovascular comorbidity risk in pediatric BD is essential, particularly differentiating between patients with and without vascular involvement.
  • Traditional cardiovascular risk factors were excluded to isolate BD-specific impacts.

Purpose of the Study:

  • To evaluate cardiovascular comorbidity risk in pediatric BD patients.
  • To compare cardiovascular risk markers in pediatric BD patients with and without vascular involvement.
  • To determine the utility of ambulatory blood pressure monitoring (ABPM) in assessing cardiovascular risk in pediatric BD.

Main Methods:

  • Included 31 pediatric BD patients meeting 2015 PEDBD criteria.
  • Utilized 24-hour ambulatory blood pressure monitoring (ABPM), transthoracic echocardiography, and carotid intima-media thickness (cIMT) measurements.
  • Excluded patients with active disease or other known cardiovascular risk factors.

Main Results:

  • 10 out of 31 (34.4%) pediatric BD patients exhibited abnormal ABPM.
  • No significant differences in ABPM parameters or cIMT were found between patients with and without vascular involvement.
  • Echocardiography revealed increased left ventricle outflow tract velocity and velocity time integral in BD patients with vascular involvement, suggesting potential aortic stiffness.

Conclusions:

  • Pediatric BD patients with vascular involvement may present with increased cardiovascular risk factors.
  • Comprehensive cardiovascular assessment is recommended for all pediatric BD patients, irrespective of specific system involvement.
  • Ambulatory blood pressure monitoring (ABPM) shows promise for accurately defining hypertension and cardiovascular risk in pediatric BD.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
46
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11